{"id":571230,"date":"2021-10-26T22:32:06","date_gmt":"2021-10-26T22:32:06","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=571230"},"modified":"2021-10-26T22:32:06","modified_gmt":"2021-10-26T22:32:06","slug":"wet-agerelated-macular-degeneration-wet-amd-market-to-witness-upsurge-in-growth-during-the-forecast-period-2030-key-companies-allergan-bioeq-alkahest-regeneron-graybug-vision-and-others","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/wet-agerelated-macular-degeneration-wet-amd-market-to-witness-upsurge-in-growth-during-the-forecast-period-2030-key-companies-allergan-bioeq-alkahest-regeneron-graybug-vision-and-others_571230.html","title":{"rendered":"Wet Age-Related Macular Degeneration (Wet AMD) Market to Witness Upsurge in Growth During the Forecast Period 2030 | Key Companies – Allergan, Bioeq, Alkahest, Regeneron, Graybug Vision, and Others"},"content":{"rendered":"
\n
\"Wet<\/a><\/div>\n
\n
Delveinsight Business Research LLP<\/div>\n<\/div>\n<\/div>\n
DelveInsight’s “Wet Age-Related Macular Degeneration (Wet AMD) Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Wet AMD Market Size and Share in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/div>\n

The Wet Age-Related Macular Degeneration (Wet AMD) market<\/strong> report covers emerging drugs, current treatment practices, market share of the individual therapies, current and forecasted market size from 2017 to 2030. It evaluates the current treatment practice\/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. <\/p>\n

\"Wet<\/p>\n

Wet Age-Related Macular Degeneration (Wet AMD): An Overview<\/strong><\/p>\n

According to American Macular Degeneration Foundation, Wet Age-Related Macular Degeneration (Wet-AMD) is a type of macular degeneration in which abnormal blood vessels (known as choroidal neovascularization or CNV) develop under the retina and macula. These abnormal blood vessels often grow and leak or bleed, causing scarring of the macula. This damage to the macula results in rapid central vision loss. Once this vision is destroyed, it cannot be restored. Wet AMD results in the exudation or leakage of fluid and blood from new blood vessels and is also called neovascular AMD or exudative AMD. <\/p>\n

Wet Age-Related Macular Degeneration (Wet AMD) Market Key Facts<\/strong><\/p>\n